Skip to content
Tasimelteon

Tasimelteon

Regular price $86.25 USD
Sale price Regular price

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Tasimelteon (BMS-214778) is a Dual Melatonin Receptor Agonist (DMRA) recently approved (Hetlioz) for the treatment of Non-24-hour sleep–wake disorder, a disorder primarily found in the totally blind, where a lack of normal synchronization between the 24-hour light–dark cycle and the endogenous circadian rhythm causes it to drift out of alignment with conventional sleep–wake schedules.
Casnumber
609799-22-6
Formula
C15H19NO2
Mw
245.32
Psmiles
CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2
Purity
>99%
Solubility
DMSO 25 mg/mL
Target synonyms
BMS-214778; VEC-162
Technical documents

Documents

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab